Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
HeraMED Ltd. ( (AU:HMD) ) just unveiled an announcement.
HeraMED Limited has appointed William Buck Audit (Vic) Pty Ltd as its new external auditor following the resignation of BDO Audit Pty Ltd, after a competitive tender process, with the appointment to be put to shareholders for ratification at the company’s 2026 Annual General Meeting. The company has also strengthened its governance framework by appointing Stephanie Vipond of Bio101 Financial Advisory as Joint Company Secretary alongside Cameron Jones, with both now responsible for ASX communications, underscoring HeraMED’s focus on compliance and corporate oversight as it advances its digital maternity care platform.
The most recent analyst rating on (AU:HMD) stock is a Hold with a A$0.03 price target. To see the full list of analyst forecasts on HeraMED Ltd. stock, see the AU:HMD Stock Forecast page.
More about HeraMED Ltd.
HeraMED Limited (ASX: HMD) is a medical data and technology company focused on digitally transforming maternity care through a hybrid care platform. Its proprietary solutions, including the HeraBEAT in-home fetal and maternal heart rate monitor and the HeraCARE integrated maternal health ecosystem, combine hardware, software, cloud computing, artificial intelligence and big data to support prenatal and postpartum care, improve patient engagement and enable early detection and prevention of risks while aiming to lower healthcare costs.
Average Trading Volume: 1,066,942
Technical Sentiment Signal: Buy
Current Market Cap: A$38.53M
See more data about HMD stock on TipRanks’ Stock Analysis page.